Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/40674
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWiendl, H.-
dc.contributor.authorBenedict, R.H.B.-
dc.contributor.authorComi, G.-
dc.contributor.authorOreja-Guevara, C.-
dc.contributor.authorSiva, A.-
dc.contributor.authorVAN WIJMEERSCH, Bart-
dc.contributor.authorBuffels, R.-
dc.contributor.authorKuenzel, T.-
dc.contributor.authorVermersch, P.-
dc.date.accessioned2023-08-03T13:52:49Z-
dc.date.available2023-08-03T13:52:49Z-
dc.date.issued2022-
dc.date.submitted2023-08-03T13:51:15Z-
dc.identifier.citation38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Amsterdam, The Netherlands and Virtual, 26–28 October 2022-
dc.identifier.urihttp://hdl.handle.net/1942/40674-
dc.language.isoen-
dc.titleEmployment and Cognitive Improvements in Ocrelizumab-Treated Patients with Relapsing-Remitting Multiple Sclerosis: 96-Week CASTING Study Data-
dc.typeConference Material-
local.bibliographicCitation.conferencedate2022, October 26-28-
local.bibliographicCitation.conferencename38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)-
local.bibliographicCitation.conferenceplaceAmsterdam, The Netherlands and Virtual-
local.bibliographicCitation.jcatC2-
local.type.refereedNon-Refereed-
local.type.specifiedConference Poster-
local.provider.typePdf-
local.uhasselt.internationalyes-
item.contributorWiendl, H.-
item.contributorBenedict, R.H.B.-
item.contributorComi, G.-
item.contributorOreja-Guevara, C.-
item.contributorSiva, A.-
item.contributorVAN WIJMEERSCH, Bart-
item.contributorBuffels, R.-
item.contributorKuenzel, T.-
item.contributorVermersch, P.-
item.fullcitationWiendl, H.; Benedict, R.H.B.; Comi, G.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Buffels, R.; Kuenzel, T. & Vermersch, P. (2022) Employment and Cognitive Improvements in Ocrelizumab-Treated Patients with Relapsing-Remitting Multiple Sclerosis: 96-Week CASTING Study Data. In: 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Amsterdam, The Netherlands and Virtual, 26–28 October 2022.-
item.accessRightsOpen Access-
item.fulltextWith Fulltext-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
poster 7 Powerpoint.pdfConference material2.27 MBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.